Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline: Response to Burrows, Li, and Geiss

Diabetes Care

Volumn 33, Issue 5, 2010, Pages

  Villar, Emmanuel ^a   Mcdonald, Stephen Peter ^b,c   Couchoud, Cécile ^d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d AGENCE DE LA BIOMÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; CHRONIC KIDNEY FAILURE; INCIDENCE; NOTE; RENAL REPLACEMENT THERAPY; STATISTICS; UNITED STATES;

DIABETIC NEPHROPATHIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; UNITED STATES;

EID: 77954921969     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0074     Document Type: Letter

References (5)

1. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010;33:73-77
2. Fioretto P, Caramori ML, Mauer M. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia 2008;51:1347-1355
3. Couchoud C, Villar E, Frimat L, Fagot-Campagna A, Stengel B. End-stage renal disease and diabetes: frequency and initial condition of replacement therapy, France, 2006. BEH 2008;43:414-418
4. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991-2005). Diabetes Care 2007;30:3070-3076
5. Villar E, Polkinghorne KR, Chang SH, Chadban SJ, McDonald SP. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease. Diabetologia 2009;52:2536-2541